Pterostilbene attenuates high fat diet-induced obesity and hepatic dysfunction.
Pterostilbene Attenuates High Fat Diet-induced Obesity and Hepatic Dysfunction in Rats: A Functional Evaluation Based on Taiwan's Health Food Assessment Criteria.
AI Summary
Key Findings
Abstract
BACKGROUND/AIM: Obesity represents a significant global health challenge and is closely linked to the prevalence of metabolic syndromes and liver disorders. In Taiwan, the Ministry of Health and Welfare has instituted specific evaluation protocols for functional foods to mitigate body fat accumulation, underscoring mechanisms beyond caloric restriction. The present study sought to assess the anti-adipogenic and metabolic effects of pterostilbene (PTS) using a rat model of high fat diet (HFD)-induced obesity, in compliance with Taiwan's regulatory standards for health claims about "difficult-to-form body fat". MATERIALS AND METHODS: Male Sprague-Dawley (SD) rats were fed a HFD for six months to induce obesity. Subsequently, the SD rats were administered PTS orally at dosages of 30 or 50 mg/kg/day for 45 days. This study evaluated various parameters, including body weight, food intake, feed efficiency, body fat percentage, liver weight, and serum biochemical markers. RESULTS: Forty-five day 30 and 50 mg/kg PTS oral treatment significantly reduced body weight gain, food intake, and feed efficiency (all
Affiliation
Chien-Jung Huang
External References
- PubMed ID:
- 41482364
Comments
Sign in or create a free account to join the conversation.
Sign in to commentBe the first to comment.